| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Rolinsatamab
CAS:2095467-30-2
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd.
|
| Tel: |
027-65317797 15926423062 |
| Email: |
422450190@qq.com |
| Products Intro: |
Product Name:Rolinsatamab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 15002144251 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Rolinsatamab
CAS:2095467-30-2
Package:1removed
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
| Products Intro: |
Product Name:Research Grade Rolinsatamab(DHD18001)
CAS:2095467-30-2
Purity:PAGE:>95% Package:100ug;1mg
|
Rolinsatamab manufacturers
- Rolinsatamab
-
- $513.00
-
2026-07-03
- CAS:2095467-30-2
- Purity: > 95%
- Supply Ability: 10g
|
| | Rolinsatamab Basic information |
| Product Name: | Rolinsatamab | | Synonyms: | Rolinsatamab;Research Grade Rolinsatamab(DHD18001);Research Grade Rolinsatamab | | CAS: | 2095467-30-2 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Rolinsatamab Structure]() |
| | Rolinsatamab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Rolinsatamab Usage And Synthesis |
| Uses | Rolinsatamab is a IgG1κ type chimeric antibody targeting to PRLR (prolactin receptor). Rolinsatamab can be conjugated with pyrrolobenzodiazepine (PDB) dimer SGD-1882 (HY-101127) via a cleavable maleimidocaproyl type linker, to form an antibody-drug conjugate, Rolinsatamab talirine. One Rolinsatamab talirine has an average of 2 site-specific drug attachment engineered cysteines (S239C). The linker equips the valine-alanine dipeptide, as cathepsine B cleavage site. on an average of 2 site-specific drug attachment engineered cysteines (S239C)[1]. | | References | [1] Anderson MG, et al. ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition. BMC Cancer. 2021 Jun 9;21(1):681. DOI:10.1186/s12885-021-08403-5 |
| | Rolinsatamab Preparation Products And Raw materials |
|